UnitedHealth Group Incorporated
UNH · CIK 0000731766 · Hospital & Medical Service Plans
Financial snapshot
Revenue
111,721,000,000
USD · 2026-03-31
Cost of Revenue
12,823,000,000
USD · 2026-03-31
Operating Income
8,990,000,000
USD · 2026-03-31
Net Income
6,280,000,000
USD · 2026-03-31
Total Assets
312,644,000,000
USD · 2026-03-31
Total Liabilities
207,325,000,000
USD · 2026-03-31
Stockholders' Equity
33,020,000,000
USD · 2015-06-30
Cash & Equivalents
28,001,000,000
USD · 2026-03-31
Financial statements
Income Statement — period ending 2026-03-31
| Line item | Value (USD) | Source filing |
|---|---|---|
| Revenue | 111,721,000,000 | 0000731766-26-000127 |
| Cost of Revenue | 12,823,000,000 | 0000731766-26-000127 |
Balance Sheet — period ending 2026-03-31
| Line item | Value (USD) | Source filing |
|---|---|---|
| Accounts Receivable, Current | 26,587,000,000 | 0000731766-26-000127 |
| Inventory | — | — |
| Property, Plant & Equipment, Net | 10,667,000,000 | 0000731766-26-000127 |
| Accounts Payable, Current | — | — |
Cash Flow Statement — period ending 2026-03-31
| Line item | Value (USD) | Source filing |
|---|---|---|
| Capital Expenditures | 763,000,000 | 0000731766-26-000127 |
Derived metrics
| Metric | Value | Unit | Period end |
|---|---|---|---|
| capex_intensity | 0.0068 | ratio | 2026-03-31 |
| gross_margin | 0.8852 | ratio | 2026-03-31 |
| inventory_turns_sales_basis | 135.6264 | ratio | 2025-12-31 |
| sales_to_ppe | 10.4735 | ratio | 2026-03-31 |
| working_capital_proxy | 26,587,000,000 | USD | 2026-03-31 |
Leadership (from SEC Forms 3/4/5)
Officers, directors, and ≥10% owners extracted from public SEC ownership filings. Tenure shown is a filing-date range (a proxy, not an official appointment record).
| Name | Title | Roles | First seen | Last seen | Net insider shares |
|---|---|---|---|---|---|
| Noseworthy John H | Director | Director | 2026-06-25 | 2026-07-06 | 823 |
| McSweeney Erin | EVP & Chief People Officer | Officer | 2026-06-25 | 2026-06-25 | 241 |
| GARCIA PAUL R | Director | Director | 2026-06-25 | 2026-07-06 | 686 |
| MONTGOMERY RICE VALERIE MD | Director | Director | 2026-06-25 | 2026-07-06 | 742 |
| Gil Kristen | Director | Director | 2026-06-25 | 2026-07-06 | 634 |
| Gottlieb Scott | Director | Director | 2026-06-25 | 2026-07-06 | 636 |
| MCNABB FREDERICK WILLIAM III | Director | Director | 2026-07-06 | 2026-07-06 | 750 |
| FLYNN TIMOTHY PATRICK | Director | Director | 2026-07-06 | 2026-07-06 | 675 |
| Baker Charles D. | Director | Director | 2026-07-06 | 2026-07-06 | 660 |
| Conway Patrick Hugh | Chief Executive Officer, Optum | Officer | 2026-06-25 | 2026-06-25 | 165 |
| Noel Timothy John | Chief Executive Officer, UHC | Officer | 2026-06-25 | 2026-06-25 | 152 |
| Zaetta Christopher R | EVP & Chief Legal Officer | Officer | 2026-06-25 | 2026-06-25 | 121 |
| DeVeydt Wayne S | Chief Financial Officer | Officer | 2026-06-25 | 2026-06-25 | 224 |
Stakeholder orientation — people vs. profits (heuristic)
Index: -0.3139 — Balanced. Scale −1 (payout / shareholder-tilted) to +1 (reinvestment / stakeholder-tilted), period ending 2025-12-31.
| Signal | Value | Score | Weight | Basis |
|---|---|---|---|---|
| Reinvestment vs. shareholder payout | -0.2914 | -0.2914 | 0.4 | +1 = all reinvested (capex+R&D); -1 = all paid to shareholders (buybacks+dividends). |
| Capex intensity (local-investment proxy) | 0.0081 | -0.8381 | 0.25 | Proxy for building physical/local capacity. NOT a direct outsourcing measure. |
| Insider alignment (net buy/sell) | 6509.15 | 0.5 | 0.15 | Directional 'skin in the game' signal from insider transactions. |
Methodology & caveats: Heuristic model over public SEC XBRL facts. Signals describe capital allocation during the period, not the character, competence, or 'approval' of any individual. capex_intensity is a proxy for physical/local investment, NOT a direct measure of outsourcing/offshoring (which XBRL does not disclose). Verify against the original filings. Not investment, financial, or HR advice.
Filings (latest 50)
| Form | Filing date | Period | Accession |
|---|---|---|---|
| 8-K | 2026-07-16 | 2026-07-16 | 0000731766-26-000191 |
| 4 | 2026-07-06 | 2026-07-01 | 0000731766-26-000189 |
| 4 | 2026-07-06 | 2026-07-01 | 0000731766-26-000187 |
| 4 | 2026-07-06 | 2026-07-01 | 0000731766-26-000185 |
| 4 | 2026-07-06 | 2026-07-01 | 0000731766-26-000183 |
| 4 | 2026-07-06 | 2026-07-01 | 0000731766-26-000181 |
| 4 | 2026-07-06 | 2026-07-01 | 0000731766-26-000179 |
| 4 | 2026-07-06 | 2026-07-01 | 0000731766-26-000177 |
| 4 | 2026-07-06 | 2026-07-01 | 0000731766-26-000175 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000173 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000172 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000171 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000170 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000169 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000168 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000167 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000166 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000165 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000164 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000163 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000162 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000161 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000160 |
| 4 | 2026-06-25 | 2026-06-23 | 0000731766-26-000159 |
| 11-K | 2026-06-11 | 2025-12-31 | 0000731766-26-000143 |
| 4 | 2026-06-09 | 2026-06-05 | 0000731766-26-000140 |
| 8-K | 2026-06-05 | 2026-06-01 | 0000731766-26-000138 |
| 4 | 2026-06-04 | 2026-06-03 | 0000731766-26-000136 |
| 4 | 2026-06-04 | 2026-06-02 | 0000731766-26-000134 |
| DEFA14A | 2026-05-15 | 0000731766-26-000132 | |
| 8-K | 2026-05-11 | 2026-05-11 | 0000731766-26-000129 |
| 10-Q | 2026-05-05 | 2026-03-31 | 0000731766-26-000127 |
| SCHEDULE 13G | 2026-04-30 | 0002100119-26-001233 | |
| 4 | 2026-04-27 | 2026-04-23 | 0000731766-26-000123 |
| 144 | 2026-04-23 | 0001959173-26-003043 | |
| DEFA14A | 2026-04-21 | 0001104659-26-046134 | |
| DEF 14A | 2026-04-21 | 2026-06-01 | 0001104659-26-046125 |
| 8-K | 2026-04-21 | 2026-04-21 | 0000731766-26-000121 |
| 4 | 2026-04-06 | 2026-04-01 | 0000731766-26-000119 |
| 4 | 2026-04-06 | 2026-04-01 | 0000731766-26-000118 |
| 4 | 2026-04-06 | 2026-04-01 | 0000731766-26-000117 |
| 4 | 2026-04-06 | 2026-04-01 | 0000731766-26-000116 |
| 4 | 2026-04-06 | 2026-04-01 | 0000731766-26-000115 |
| 4 | 2026-04-06 | 2026-04-01 | 0000731766-26-000114 |
| 4 | 2026-04-06 | 2026-04-01 | 0000731766-26-000113 |
| 4 | 2026-04-06 | 2026-04-01 | 0000731766-26-000112 |
| 4 | 2026-04-06 | 2026-04-01 | 0000731766-26-000111 |
| SCHEDULE 13G/A | 2026-03-27 | 0000102909-26-002526 | |
| 4 | 2026-03-19 | 2026-03-17 | 0000731766-26-000101 |
| 4 | 2026-03-19 | 2026-03-17 | 0000731766-26-000100 |
XBRL facts (showing 100 of 28836)
| Concept | Taxonomy | Period start | Period end | Unit | Value |
|---|---|---|---|---|---|
| EntityCommonStockSharesOutstanding | dei | 2026-04-30 | shares | 908,144,404 | |
| AccountsPayableAndAccruedLiabilitiesCurrent | us-gaap | 2026-03-31 | USD | 38,631,000,000 | |
| AccountsReceivableNetCurrent | us-gaap | 2026-03-31 | USD | 26,587,000,000 | |
| AccumulatedOtherComprehensiveIncomeLossNetOfTax | us-gaap | 2026-03-31 | USD | -2,562,000,000 | |
| AdditionalPaidInCapital | us-gaap | 2026-03-31 | USD | 556,000,000 | |
| AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | us-gaap | 2026-01-01 | 2026-03-31 | shares | 18,000,000 |
| Assets | us-gaap | 2026-03-31 | USD | 312,644,000,000 | |
| AssetsCurrent | us-gaap | 2026-03-31 | USD | 91,127,000,000 | |
| AssetsFairValueDisclosure | us-gaap | 2026-03-31 | USD | 80,964,000,000 | |
| AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | us-gaap | 2026-03-31 | USD | 116,000,000 | |
| AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | us-gaap | 2026-03-31 | USD | 1,877,000,000 | |
| AvailableForSaleDebtSecuritiesAmortizedCostBasis | us-gaap | 2026-03-31 | USD | 51,867,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost | us-gaap | 2026-03-31 | USD | 12,664,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue | us-gaap | 2026-03-31 | USD | 12,254,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost | us-gaap | 2026-03-31 | USD | 14,106,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | us-gaap | 2026-03-31 | USD | 13,770,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost | us-gaap | 2026-03-31 | USD | 7,685,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue | us-gaap | 2026-03-31 | USD | 7,414,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost | us-gaap | 2026-03-31 | USD | 3,334,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | us-gaap | 2026-03-31 | USD | 3,316,000,000 | |
| AvailableForSaleSecuritiesDebtSecurities | us-gaap | 2026-03-31 | USD | 50,106,000,000 | |
| CashAndCashEquivalentsAtCarryingValue | us-gaap | 2026-03-31 | USD | 28,001,000,000 | |
| CashAndCashEquivalentsFairValueDisclosure | us-gaap | 2026-03-31 | USD | 28,001,000,000 | |
| CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | us-gaap | 2026-03-31 | USD | 28,001,000,000 | |
| CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | us-gaap | 2026-01-01 | 2026-03-31 | USD | 3,636,000,000 |
| CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations | us-gaap | 2026-01-01 | 2026-03-31 | USD | 3,466,000,000 |
| CommonStockDividendsPerShareCashPaid | us-gaap | 2026-01-01 | 2026-03-31 | USD/shares | 2 |
| CommonStockParOrStatedValuePerShare | us-gaap | 2026-03-31 | USD/shares | 0 | |
| CommonStockSharesAuthorized | us-gaap | 2026-03-31 | shares | 3,000,000,000 | |
| CommonStockSharesIssued | us-gaap | 2026-03-31 | shares | 908,000,000 | |
| CommonStockSharesOutstanding | us-gaap | 2026-03-31 | shares | 908,000,000 | |
| CommonStockValue | us-gaap | 2026-03-31 | USD | 9,000,000 | |
| ComprehensiveIncomeNetOfTax | us-gaap | 2026-01-01 | 2026-03-31 | USD | 5,779,000,000 |
| ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest | us-gaap | 2026-01-01 | 2026-03-31 | USD | 201,000,000 |
| ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | us-gaap | 2026-01-01 | 2026-03-31 | USD | 5,980,000,000 |
| CostOfGoodsAndServicesSold | us-gaap | 2026-01-01 | 2026-03-31 | USD | 12,823,000,000 |
| CostsAndExpenses | us-gaap | 2026-01-01 | 2026-03-31 | USD | 102,731,000,000 |
| DebtCurrent | us-gaap | 2026-03-31 | USD | 6,477,000,000 | |
| DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostBeforeAllowanceForCreditLoss | us-gaap | 2026-03-31 | USD | 52,341,000,000 | |
| DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain | us-gaap | 2026-03-31 | USD | 117,000,000 | |
| DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss | us-gaap | 2026-03-31 | USD | 1,881,000,000 | |
| DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue | us-gaap | 2026-03-31 | USD | 50,577,000,000 | |
| DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | us-gaap | 2026-03-31 | pure | 31,000 | |
| DeferredIncomeTaxExpenseBenefit | us-gaap | 2026-01-01 | 2026-03-31 | USD | 540,000,000 |
| DeferredIncomeTaxLiabilitiesNet | us-gaap | 2026-03-31 | USD | 2,864,000,000 | |
| DeferredRevenueCurrent | us-gaap | 2026-03-31 | USD | 3,419,000,000 | |
| DepreciationAndAmortization | us-gaap | 2026-01-01 | 2026-03-31 | USD | 1,029,000,000 |
| DividendsCash | us-gaap | 2026-01-01 | 2026-03-31 | USD | 2,005,000,000 |
| EarningsPerShareBasic | us-gaap | 2026-01-01 | 2026-03-31 | USD/shares | 7 |
| EarningsPerShareDiluted | us-gaap | 2026-01-01 | 2026-03-31 | USD/shares | 7 |
| EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | us-gaap | 2026-01-01 | 2026-03-31 | USD | -7,000,000 |
| EquityMethodInvestments | us-gaap | 2026-03-31 | USD | 3,900,000,000 | |
| EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue | us-gaap | 2026-03-31 | USD | 5,500,000,000 | |
| EquitySecuritiesFvNiCurrentAndNoncurrent | us-gaap | 2026-03-31 | USD | 1,977,000,000 | |
| EquitySecuritiesWithoutReadilyDeterminableFairValueAmount | us-gaap | 2026-03-31 | USD | 3,500,000,000 | |
| EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount | us-gaap | 2026-03-31 | USD | 933,000,000 | |
| FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | us-gaap | 2026-01-01 | 2026-03-31 | USD | 0 |
| FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | us-gaap | 2026-01-01 | 2026-03-31 | USD | 0 |
| Goodwill | us-gaap | 2026-03-31 | USD | 110,512,000,000 | |
| HeldToMaturitySecurities | us-gaap | 2026-03-31 | USD | 474,000,000 | |
| HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain | us-gaap | 2026-03-31 | USD | 1,000,000 | |
| HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss | us-gaap | 2026-03-31 | USD | 4,000,000 | |
| HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue | us-gaap | 2026-03-31 | USD | 4,000,000 | |
| HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount | us-gaap | 2026-03-31 | USD | 4,000,000 | |
| HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | us-gaap | 2026-03-31 | USD | 185,000,000 | |
| HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount | us-gaap | 2026-03-31 | USD | 186,000,000 | |
| HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue | us-gaap | 2026-03-31 | USD | 14,000,000 | |
| HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount | us-gaap | 2026-03-31 | USD | 17,000,000 | |
| HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue | us-gaap | 2026-03-31 | USD | 268,000,000 | |
| HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount | us-gaap | 2026-03-31 | USD | 267,000,000 | |
| HeldToMaturitySecuritiesFairValue | us-gaap | 2026-03-31 | USD | 471,000,000 | |
| IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | us-gaap | 2026-01-01 | 2026-03-31 | USD | 7,963,000,000 |
| IncomeTaxExpenseBenefit | us-gaap | 2026-01-01 | 2026-03-31 | USD | 1,482,000,000 |
| IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | us-gaap | 2026-01-01 | 2026-03-31 | USD | 1,055,000,000 |
| IncreaseDecreaseInAccountsReceivable | us-gaap | 2026-01-01 | 2026-03-31 | USD | 3,544,000,000 |
| IncreaseDecreaseInDeferredRevenue | us-gaap | 2026-01-01 | 2026-03-31 | USD | 20,000,000 |
| IncreaseDecreaseInDeposits | us-gaap | 2026-01-01 | 2026-03-31 | USD | 600,000,000 |
| IncreaseDecreaseInHealthCareInsuranceLiabilities | us-gaap | 2026-01-01 | 2026-03-31 | USD | 296,000,000 |
| IncreaseDecreaseInOtherOperatingAssets | us-gaap | 2026-01-01 | 2026-03-31 | USD | -2,919,000,000 |
| IntangibleAssetsNetExcludingGoodwill | us-gaap | 2026-03-31 | USD | 20,093,000,000 | |
| InterestExpense | us-gaap | 2026-01-01 | 2026-03-31 | USD | 955,000,000 |
| InvestmentIncomeInterestAndDividend | us-gaap | 2026-01-01 | 2026-03-31 | USD | 1,131,000,000 |
| InvestmentOwnedBalanceContracts | us-gaap | 2026-03-31 | pure | 42,000 | |
| Liabilities | us-gaap | 2026-03-31 | USD | 207,325,000,000 | |
| LiabilitiesAndStockholdersEquity | us-gaap | 2026-03-31 | USD | 312,644,000,000 | |
| LiabilitiesCurrent | us-gaap | 2026-03-31 | USD | 114,124,000,000 | |
| LiabilityForClaimsAndClaimsAdjustmentExpense | us-gaap | 2026-03-31 | USD | 39,659,000,000 | |
| LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1 | us-gaap | 2026-01-01 | 2026-03-31 | USD | 44,021,000,000 |
| LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1 | us-gaap | 2026-01-01 | 2026-03-31 | USD | 29,205,000,000 |
| LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount | us-gaap | 2026-03-31 | USD | 27,600,000,000 | |
| LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 | us-gaap | 2026-01-01 | 2026-03-31 | USD | 73,489,000,000 |
| LoansReceivableFairValueDisclosure | us-gaap | 2026-03-31 | USD | 880,000,000 | |
| LongTermDebtNoncurrent | us-gaap | 2026-03-31 | USD | 71,440,000,000 | |
| LongTermInvestments | us-gaap | 2026-03-31 | USD | 56,788,000,000 | |
| MinorityInterest | us-gaap | 2026-03-31 | USD | 6,014,000,000 | |
| MinorityInterestChangeInRedemptionValue | us-gaap | 2026-01-01 | 2026-03-31 | USD | 51,000,000 |
| MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders | us-gaap | 2026-01-01 | 2026-03-31 | USD | 164,000,000 |
| MinorityInterestPeriodIncreaseDecrease | us-gaap | 2026-01-01 | 2026-03-31 | USD | 31,000,000 |
| NetCashProvidedByUsedInFinancingActivities | us-gaap | 2026-01-01 | 2026-03-31 | USD | -2,992,000,000 |
| NetCashProvidedByUsedInInvestingActivities | us-gaap | 2026-01-01 | 2026-03-31 | USD | -2,447,000,000 |
Download data
Full profile (JSON)XBRL facts (CSV)Derived metrics (CSV)Statements (CSV)Filings (CSV)